Company Details
TriArm Therapeutics
200 Niudun Road Building 5, Suite 502, Shanghai, 200030, China
Overview
TriArm Therapeutics is focused on developing cell therapies. The company completed a $20 million Series A financing. The fundraising was reported in an article published July 30, 2019. The announcement appeared on the ChinaBio Group site, which covers life‑science industry news and advisory services. The article does not include operating metrics, investor names, or additional financial terms.
- Total raised
- $20M
- Funding rounds
- 1
- Latest round
- Series A
- Latest activity
- Jul 2019
Industries
- Biotechnology
- Health Care
Recent funding
Series A
Jul 2019
$20M
Team
Jay Zhang
Co-Founder & Chief Executive Officer
Douglas E. Williams
CEO
LinkedInJinhua Lu
Co-Founder & Chief Scientific Officer